Claritas Outlines Development Strategy For R-107 For Multiple Diseases, Disorders And Injuries
Published by The Street By GlobeNewswire SAN FRANCISCO, CA and TORONTO, ON, Jan. 04, 2022 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and